"El Hospital Quirónsalud Sagrado Corazón es un centro sanitario médico-quirúrgico de referencia, dedicado al cuidado de la salud entendida como prevención, diagnóstico, tratamiento y educación sanitaria del paciente. Nuestra política se centra en tener como alidados a profesionales de la más alta cualificación y prestigio, contar con tecnología de vanguardia, prestando especial interés a la calidad de nuestro servicio asistencial dentro de un entorno con un alto nivel de confort para nuestros pacientes y sus familiares."

During the past decade, Hospital Quiron Sagrado Corazon conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Quiron Sagrado Corazon" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "SOLTI Breast Cancer Research Group" with 3 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Quiron Sagrado Corazon" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "AKRN Scientific Consulting, S.L." with 1 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Quiron Sagrado Corazon" are "Metastatic Breast Cancer" (3 trials), "Arthritis, Psoriatic" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Breast Cancer" (1 trials) and "Breast Cancer Metastatic" (1 trials). Many other conditions were trialed in "Hospital Quiron Sagrado Corazon" in a lesser frequency.

Most popular intervention types in "Hospital Quiron Sagrado Corazon" are "Drug" (14 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Guselkumab" (2 trials) and "Palbociclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Quiron Sagrado Corazon" are 15 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Quiron Sagrado Corazon". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Quiron Sagrado Corazon, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Quiron Sagrado Corazon, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".